Population pharmacokinetic modeling and noncompartmental analysis demonstrated bioequivalence between metformin component of metformin/vildagliptin fixed-dose combination products and metformin immediate-release tablet sourced from various countries-Reference-Cited by-同舟云学术

Population pharmacokinetic modeling and noncompartmental analysis demonstrated bioequivalence between metformin component of metformin/vildagliptin fixed-dose combination products and metformin immediate-release tablet sourced from various countries

Published:2015-05-15 Issue:1 Volume:5 Page:40-51
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Chitnis Shripad D.¹,Han Yi²,Yamaguchi Masayuki³,Mita Sachiko³,Zhao Rong²,Sunkara Gangadhar⁴,Kulmatycki Kenneth¹

Affiliation:

1. Novartis Institutes for BioMedical Research, Cambridge; MA USA

2. Novartis Institutes for BioMedical Research; Shanghai China

3. Novartis Pharma K.K.; Tokyo Japan

4. Novartis Institutes for BioMedical Research; East Hanover; NJ USA

Funder

Novartis Pharmaceutical Inc.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference40 articles.

1. Metformin as first choice in oral diabetes treatment: the UKPDS experience;Holman;Journees annuelles de diabetologie de l'Hotel-Dieu.,2007

2. http://www.news-medical.net/health/Metformin-History.aspx

3. Clinical pharmacokinetics of metformin;Graham;Clin Pharmacokinet.,2011

4. Clinical pharmacokinetics of metformin;Scheen;Clin Pharmacokinet.,1996

5. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus;Dunn;Drugs.,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment;Pharmaceuticals;2024-07-10

2. Pharmacokinetics and Bioequivalence of Two Combination Metformin/Glipizide Tablets under Fasting and Fed Conditions in Chinese Healthy Subjects: A Randomized, Open-Label, Crossover Study;Journal of Clinical Pharmacy and Therapeutics;2024-04-10

3. Evaluation of OCT2‐mediated drug–drug interactions between ulotaront and metformin in subjects with schizophrenia;Pharmacology Research & Perspectives;2024-03-25

4. Research Progress of Population Pharmacokinetic of Metformin;BioMed Research International;2022-12-19

5. Utilization of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacoepidemiological Studies: A Systematic Review on Antiarrhythmic and Glucose-Lowering Medicines;Frontiers in Pharmacology;2022-06-20